Judge Says Janssen Alzheimer's Patent Invalid
A federal judge has ruled that Janssen Pharmaceutica Inc.'s Alzheimer's drug patent is invalid for lack of enablement in a victory for several generic-drug makers accused of infringing the patent....To view the full article, register now.
Already a subscriber? Click here to view full article